Meeting
2018 ASCO Annual Meeting
Predictors of differential response to induction chemotherapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG).
Authors
Navin R. Pinto
Seattle Children’s Hospital, Seattle, WA
Navin R. Pinto , Emily Hibbitts , Susan G. Kreissman , Meaghan P. Granger , Meredith Irwin , Rochelle Bagatell , Wendy B. London , Emily Gustava Greengard , Arlene Naranjo , Julie R. Park , Steven G. DuBois
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Pediatric Solid Tumors
Citation
J Clin Oncol 36, 2018 (suppl; abstr 10532)
DOI
10.1200/JCO.2018.36.15_suppl.10532
Abstract #
10532
Poster Bd #
205
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Predictors of differential outcomes according to response to induction chemotherapy in high-risk neuroblastoma.
First Author: Elizabeth Sokol
Poster
2022 ASCO Quality Care Symposium
Association of race, ethnicity, and socioeconomic characteristics as predictors of cachexia risk and survival in stage IV non–small cell lung cancer (NSCLC).
First Author: Santiago Olaechea
Poster
2022 ASCO Annual Meeting
Nivolumab timing as a major survival predictor in patients with stage IV non–small cell lung cancer.
First Author: Abdoulaye Karaboué
Poster
2022 ASCO Annual Meeting
Clinical and biological features prognostic of survival after relapse of INRGSS-stage MS pattern neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
First Author: Kevin M. Campbell